Home » FDA Predictive Drug Safety Models, Biomarkers Could Guide Industry
FDA Predictive Drug Safety Models, Biomarkers Could Guide Industry
The FDA plans to develop predictive models for preclinical drug safety and efficacy and identify more biomarkers to predict responses to these drugs — knowledge that could influence drugmakers’ development and marketing decisions.
Washington Drug Letter
Washington Drug Letter
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May